关于肝素、鱼精蛋白和聚凝胺诱导血小板聚集的机制。 - Suppr

Suppr

超能文献

On the mechanism of platelet aggregation induced by heparin, protamine and polybrene.

作者信息

Eika C

出版信息

Scand J Haematol. 1972;9(3):248-57. doi: 10.1111/j.1600-0609.1972.tb00937.x.

DOI:10.1111/j.1600-0609.1972.tb00937.x

PMID:4626630

Abstract

摘要

相似文献

On the mechanism of platelet aggregation induced by heparin, protamine and polybrene.

Scand J Haematol. 1972;9(3):248-57. doi: 10.1111/j.1600-0609.1972.tb00937.x.

Thrombocytopenia in rabbits induced by heparin, protamine, and polybrene.

Scand J Haematol. 1971;8(6):481-6. doi: 10.1111/j.1600-0609.1971.tb00902.x.

Effect of heparin on platelet adhesiveness.

Acta Haematol. 1969;41(5):264-75. doi: 10.1159/000208861.

Avian thrombocyte aggregation and shape change in vitro.

Am J Physiol. 1973 Aug;225(2):340-3. doi: 10.1152/ajplegacy.1973.225.2.340.

On the mechanism of the induction of the platelet release reaction.

Acta Univ Carol Med Monogr. 1972;53:69-74.

Electrokinetic phenomena and platelet aggregation. I. Electrokinetic studies.

Acta Univ Carol Med Monogr. 1972;53:53-7.

Platelet aggregation by large molecules.

Ser Haematol. 1973;6(3):382-91.

[Antagonistic effects of heparin and protamine sulfate on the electrophoretic mobility of blood platelets].

Pathol Biol (Paris). 1969 Aug-Sep;17(15):729-32.

Human platelet clumping by bovine fibrinogen.

Acta Univ Carol Med Monogr. 1972;53:21-6.

Pharmacology of platelet-suppressive agents.

Semin Thromb Hemost. 1979 Spring;5(4):293-315. doi: 10.1055/s-0028-1087160.

引用本文的文献

The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents.

Mar Drugs. 2019 Sep 17;17(9):539. doi: 10.3390/md17090539.

The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin.

Front Pharmacol. 2016 Mar 17;7:60. doi: 10.3389/fphar.2016.00060. eCollection 2016.

Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.

Blood. 2011 May 5;117(18):4946-52. doi: 10.1182/blood-2010-09-307751. Epub 2011 Mar 2.

Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor.

J Korean Med Sci. 2010 Nov;25(11):1601-8. doi: 10.3346/jkms.2010.25.11.1601. Epub 2010 Oct 26.

Nadroparine-induced skin necrosis on a patient with essential thrombocythaemia: a case report.

Cases J. 2009 Mar 10;2:6458. doi: 10.1186/1757-1626-0002-0000006458.

Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model.

AAPS PharmSci. 2001;3(3):E19. doi: 10.1208/ps030319.

Ethyleneglycol-bis-(beta-aminoethylether)tetraacetate as a blood anticoagulant: preservation of antigen-presenting cell function and antigen-specific proliferative response of peripheral blood mononuclear cells from stored blood.

Clin Diagn Lab Immunol. 2000 Jul;7(4):578-83. doi: 10.1128/CDLI.7.4.578-583.2000.

Effects of heparin on platelet aggregation and release and thromboxane A2 production.

Am J Pathol. 1981 Aug;104(2):132-41.

Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation.

Br J Pharmacol. 1981 Jul;73(3):639-47. doi: 10.1111/j.1476-5381.1981.tb16799.x.

Effect of heparin and heparin fractions on platelet aggregation.

J Clin Invest. 1980 Jan;65(1):64-73. doi: 10.1172/JCI109661.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验